JP2017532329A5 - - Google Patents

Download PDF

Info

Publication number
JP2017532329A5
JP2017532329A5 JP2017518431A JP2017518431A JP2017532329A5 JP 2017532329 A5 JP2017532329 A5 JP 2017532329A5 JP 2017518431 A JP2017518431 A JP 2017518431A JP 2017518431 A JP2017518431 A JP 2017518431A JP 2017532329 A5 JP2017532329 A5 JP 2017532329A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
solvent
alken
unsubstituted aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017532329A (ja
JP6755859B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/055899 external-priority patent/WO2016061437A1/en
Publication of JP2017532329A publication Critical patent/JP2017532329A/ja
Publication of JP2017532329A5 publication Critical patent/JP2017532329A5/ja
Application granted granted Critical
Publication of JP6755859B2 publication Critical patent/JP6755859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518431A 2014-10-17 2015-10-16 アムホテリシンbの毒性が低減された誘導体の規模変更可能な合成法 Active JP6755859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462065330P 2014-10-17 2014-10-17
US62/065,330 2014-10-17
PCT/US2015/055899 WO2016061437A1 (en) 2014-10-17 2015-10-16 Scalable synthesis of reduced toxicity derivative of amphotericin b

Publications (3)

Publication Number Publication Date
JP2017532329A JP2017532329A (ja) 2017-11-02
JP2017532329A5 true JP2017532329A5 (enExample) 2018-11-22
JP6755859B2 JP6755859B2 (ja) 2020-09-16

Family

ID=55747385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518431A Active JP6755859B2 (ja) 2014-10-17 2015-10-16 アムホテリシンbの毒性が低減された誘導体の規模変更可能な合成法

Country Status (5)

Country Link
US (2) US10087206B2 (enExample)
EP (1) EP3206695B1 (enExample)
JP (1) JP6755859B2 (enExample)
AU (2) AU2015331904B2 (enExample)
WO (1) WO2016061437A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015175875A1 (en) * 2014-05-16 2015-11-19 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
US10087206B2 (en) * 2014-10-17 2018-10-02 The Board Of Trustees Of The University Of Illinois Scalable synthesis of reduced toxicity derivative of amphotericin B
EP3929203A1 (en) 2015-04-15 2021-12-29 Sfunga Therapeutics, Inc. Derivatives of amphotericin b
CA3149819A1 (en) * 2019-08-08 2021-02-11 The Board Of Trustees Of The University Of Illinois Hybrid amphotericin b derivatives with reduced toxicity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1008720A (en) 1910-11-14 1911-11-14 John Knape Adjustable bracket.
EP0431874A1 (en) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Novel compounds
ES2405329T3 (es) * 2003-12-30 2013-05-30 Xenoport, Inc. Síntesis de profármacos de carbarnato de aciloxialquilo y productos intermedios de los mismos
WO2014059436A1 (en) * 2012-10-12 2014-04-17 The Board Of Trustees Of The University Of Illinois Electronic tuning of site selectivity
WO2014165676A1 (en) * 2013-04-03 2014-10-09 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
WO2015175875A1 (en) 2014-05-16 2015-11-19 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
BR112016028890A8 (pt) * 2014-06-12 2021-03-23 Shionogi & Co composto derivado de macrolídeo de polieno, composição farmacêutica compreendendo o referido composto e processo para a preparação do mesmo
US10087206B2 (en) * 2014-10-17 2018-10-02 The Board Of Trustees Of The University Of Illinois Scalable synthesis of reduced toxicity derivative of amphotericin B

Similar Documents

Publication Publication Date Title
RU2013139338A (ru) Способ получения 4-амино-5-фтор-3-галоген-6-(замещенных)пиколинатов
JP2017505801A5 (enExample)
JP2008523069A5 (enExample)
JP2018529687A5 (enExample)
JP2019527228A5 (enExample)
JP6050358B2 (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
JP2010503694A5 (enExample)
JP2017501123A5 (enExample)
JP2015227339A5 (enExample)
JP2010525122A5 (enExample)
JP2018516843A5 (enExample)
JP2013534911A5 (enExample)
JP6400869B1 (ja) 4,5−ジシアノ−2−(フルオロアルキル)イミダゾールの製造方法
JP2010235601A5 (enExample)
RU2015128095A (ru) Способ получения 4-амино-5-фтор-3-хлор-6-(замещенных)пиколинатов
JP2013527149A5 (enExample)
JP7049604B2 (ja) ペンタフルオロスルファニル芳香族化合物の製造方法
JP2016516809A5 (enExample)
JP2014009330A5 (enExample)
JP2018520134A5 (enExample)
JP2009084193A (ja) チアゾリウム塩
US10508072B2 (en) Method for producing acid halide solution, mixed solution, and method for producing monoester compound
JP2017101118A5 (enExample)
JP6535915B2 (ja) 1−(5,5−ジメチルシクロヘキサ−1−エン−1−イル)エタノンおよび1−(5,5−ジメチルシクロヘキサ−6−エン−1−イル)エタノンの生成のプロセス
JP2012214427A (ja) 1,2−ベンズイソチアゾリン−3−オンを含有する水性組成物の製造方法